EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

CPAP therapy has been found to significantly reduce the risk of death for people with obstructive...

Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...

Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.

Content from other channels on our network

GLP-1 weight loss drugs' effect on food and drink choices

Heat and Control announces acquisition of Tek-Dry Systems and Hunt Heat Exchangers

Meat industry handling and freezing solutions on show at IFFA

Making the mark for egg producers

$25K FaBA grant to advance antibiotic detection in food

APHA calls "bulldust" on claims insurers cannot pay in full

Healthscope proposes Northern Beaches Hospital 'hand-back'

IVF incident: "All of us at Monash IVF are devastated"

All metropolitan public hospitals miss out on green light

Psychologist training pathway review launched

Rising cyber threats to Australia's industrial sector demand urgent action

Cyber attacks on water and electricity operators on the rise: study

Greensteel Australia to build next‍-‍generation steel mill

Omron and Cognizant partner on IT‍–‍OT integration

Encoders in motion control applications: Noise and signal distortion considerations